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Summary
Many viruses target the polarized epithelial apex
during host invasion. In contrast, hepatitis C virus
(HCV) engages receptors at the basal surface of
hepatocytes in the polarized liver parenchyma.
Hepatocyte polarization limits HCV entry by unde-
fined mechanism(s). Given the recent reports high-
lighting a role for receptor mobility in pathogen
entry, we studied the effect(s) of hepatocyte polari-
zation on viral receptor and HCV pseudoparticle
(HCVpp) dynamics using real-time fluorescence
recovery after photobleaching and single particle
tracking. Hepatoma polarization reduced CD81 and
HCVpp dynamics at the basal membrane. Since
cell polarization is accompanied by changes in the
actin cytoskeleton and CD81 links to actin via its
C-terminus, we studied the dynamics of a mutant
CD81 lacking a C-terminal tail (CD81DC) and its
effect(s) on HCVpp mobility and infection. CD81DC
showed an increased frequency of confined trajec-
tories and a reduction of Brownian diffusing
molecules compared to wild-type protein in non-
polarized cells. However, these changes were not
observed in polarized cells. HCVpp showed a
significant reduction in Brownian diffusion and
infection of CD81DC expressing non-polarized cells.
In summary, these data highlight the dynamic
nature of CD81 and demonstrate a role for CD81
lateral diffusion to regulate HCV infection in a
polarization-dependent manner.
Introduction
Hepatitis C virus (HCV) is a member of the Flaviviridae
family and an important human pathogen that infects
hepatocytes leading to progressive liver disease including
fibrosis, cirrhosis and hepatocellular carcinoma. At
present there is no HCV vaccine and there is an interna-
tional effort to develop new antiviral agents. A number of
drugs targeting HCV replicase enzymes are in develop-
ment; however, recent trials show a rapid appearance of
drug-resistant viruses (Asselah and Marcellin, 2011; Paw-
lotsky, 2011). The essential and conserved nature of HCV
entry into host cells offers an attractive target for thera-
peutic intervention. HCV initiates infection by attaching to
molecules or receptors at the cell surface. Current evi-
dence supports a role for scavenger receptor class B
member I (SR-BI), tetraspanin CD81 and tight junction
proteins claudin-1 and occludin in co-ordinating a clathrin-
dependent endocytic internalization of HCV; however, the
role of individual receptors in this process is unclear
(reviewed in Meredith et al., 2012).
SR-BI and CD81 bind HCV-encoded E1E2 glycopro-
teins with high affinity (Pileri et al., 1998; Scarselli et al.,
2002), suggesting a classical role in defining particle
attachment to the cell surface. In contrast, there is limited
information demonstrating claudin-1 or occludin interac-
tion with HCV, suggesting an indirect role for these pro-
teins in particle entry. SR-BI is the major receptor for
high-density lipoprotein (Krieger, 2001) and mediates the
trafficking of cholesterol to and from lipoproteins by selec-
tive cholesterol uptake and cholesterol efflux (Acton et al.,
1996; Rhainds and Brissette, 2004; Nieland et al., 2005).
CD81 is a member of the tetraspanin family that has
diverse roles in cell–cell adhesion, cell migration and
immune cell function (Hemler, 2005). One distinctive
feature of this protein family is their propensity to associ-
ate with other tetraspanin and non-tetraspanin proteins to
form multimolecular complexes or tetraspanin-enriched
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areas or microdomains (TEAs or TEMs) (Hemler, 2005;
Levy and Shoham, 2005). CD81 links to the cytoskeleton
via its C-terminal association with phosphorylated ezrin
(Sala-Valdes et al., 2006; Coffey et al., 2009), a member
of the ezrin–radixin–moesin (ERM) family of proteins, pro-
viding a mechanism for HCV to access the actin cytoskel-
eton and promote virus internalization. Our recent
observation that HCV increases CD81 endocytosis and
fusion with Rab5 expressing early endosomes supports a
role for CD81 in clathrin-dependent internalization of HCV
(Farquhar et al., 2012).
Hepatocytes in the liver are polarized with a basal
surface facing the circulation and a branched network of
grooves between adjacent cells constituting the apical
or bile canalicular surface (Decaens et al., 2008). HCV
entering the liver via the sinusoidal blood will initially
encounter receptors expressed at the basal surface of
the hepatocyte. This is in contrast to airway pathogens
(rhinovirus, respiratory syncytial virus and influenza) or
enteric viruses (enteroviruses and rotaviruses) that infect
polarized epithelia lining the lung airways or gastrointes-
tinal tract, respectively, via the apical membrane that is
known to restrict the movement of pathogens and macro-
molecules across mucosa (reviewed in Bergelson, 2009;
Delorme-Axford and Coyne, 2011). We previously
reported that hepatoma polarization restricts HCV entry
(Mee et al., 2009), suggesting that the reduced accessi-
bility of apical located tight junction proteins contributes to
the limited infection of polarized cells. However, recent
reports from our laboratory showing that non-junctional
pools of claudin-1 associate with CD81 at the basal mem-
brane challenge this model and raise questions as to the
mechanism(s) restricting infection of polarized hepato-
cytes (Harris et al., 2008; 2010). Thus, the molecular
mechanism(s) Coxsackie B virus and adenovirus have
evolved to infect polarized epithelia via the apical surface
(Coyne and Bergelson, 2006; Lutschg et al., 2011) may
not be the most appropriate models for HCV or other liver
tropic pathogens that target the basal hepatocellular
membrane.
Advances in imaging technologies to track virus parti-
cles demonstrate an essential role for receptor mobility in
pathogen entry (Mellman and Nelson, 2008; Burckhardt
and Greber, 2009). To ascertain a role for SR-BI and
CD81 dynamics in HCV infection, we used fluorescence
recovery after photobleaching (FRAP) and single particle
tracking (SPT) techniques to quantify receptor and HCV
pseudoparticle (HCVpp) diffusion in polarized and non-
polarized hepatocytes. Our real-time imaging studies
show reduced lipid, CD81 and HCVpp dynamics at the
basal membrane of polarized HepG2 cells compared to
non-polarized cells. Furthermore, we show a role for the
CD81 C-terminus in defining protein mobility and HCVpp
diffusion. In summary, this study highlights the dynamic
nature of CD81 and demonstrates a role for CD81 lateral
diffusion in HCV infection of hepatoma cells that is
dependent on their polarized status.
Results
Fluidity of the basolateral membrane
We previously reported that hepatoma polarization limits
HCV entry (Mee et al., 2009); however, the mechanism
underlying this restriction is unknown. The HepG2
hepatoma cell line is a well-characterized model system
that polarizes over time and develops apical lumen that
represents bile canaliculae (Ohgaki et al., 2010). Polariza-
tion is accompanied by a segregation of plasma mem-
brane lipids and proteins to apical and basal membranes.
Since membrane fluidity or viscosity is affected by many
factors including lipid composition, we investigated poten-
tial differences in lipid mobility between polarized and
non-polarized HepG2 membranes using fluorescent lipid
probes. We used FRAP to quantify the apparent diffusion
coefficient (DC) of fluorescent lipophilic carbocyanine
dyes DiD-C18 and DiO-C18. These lipids incorporate into
cell membranes and diffuse according to the lamellar
order of the membrane (Klausner and Wolf, 1980; Ladha
et al., 1997). Normalized FRAP recovery curves for DiO
and DiD are shown in Fig. 1 that take into account back-
ground fluctuations and the effect of photobleaching
during image acquisition. Rapid FRAP measurements
(0.08 s per frame) show a significantly slower diffusion of
both lipids in polarized HepG2 cells (DC = 0.17 mm2 s-1)
compared to non-polarized cells (DC = 0.43–0.45 mm2 s-1)
(Fig. 1). This change in membrane environment may con-
tribute to the reduced HCVpp entry observed in polarized
cells.
Hepatitis C virus receptor mobility on polarized
HepG2 cells
Recent studies have highlighted the importance of host
cell transmembrane receptor dynamics in regulating virus
particle trafficking (Burckhardt and Greber, 2009). We
therefore studied the effect of HepG2 polarization on the
dynamics of HCV ‘receptors’ CD81 and SR-BI. HepG2
cells were transduced to express Aequorea coerulescens
green fluorescent protein (AcGFP)-tagged CD81 or SR-BI
and the basal surface imaged by total internal reflection
fluorescence (TIRF) microscopy (Fig. 2A and D). Flow
cytometry confirmed comparable levels of CD81 and
SR-BI expression in the transduced cells compared to
endogenous protein in primary human hepatocytes (PHH)
and Huh-7.5 hepatoma cells (mean fluorescent intensity
of CD81 on PHH – 103, HepG2-CD81 – 94, Huh-7.5 – 99
and SR-BI on PHH – 89, HepG2-CD81 – 99, Huh-7.5 –
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104). In polarized HepG2 cells, the mobile fraction of
CD81 was significantly reduced (polarized Mf = 52%
versus non-polarized Mf = 67%). Furthermore, the
median CD81 diffusion coefficient was similarly reduced
in polarized cells (polarized DC = 0.07 mm2 s-1 versus
non-polarized DC = 0.11 mm2 s-1) (Fig. 2C). In contrast,
SR-BI FRAP values were comparable in polarized and
non-polarized HepG2 cells (Fig. 2E and F). Comparable
DC values for AcGFP-tagged CD81 and SR-BI were
observed in non-polarized PHH and two independent
hepatoma cell lines, Huh-6 and Huh-7.5 (Table 1).
To expand and verify the population-based FRAP experi-
ments that do not account for stochastic events such as
flow or constraints within the membrane, we measured
CD81 dynamics by SPT anti-CD81 Fabs labelled with a
single Atto647N fluorescent probe, as previously reported
for tetraspanin CD9 (Espenel et al., 2008). We selected
two anti-CD81 mAbs 2s66 and 2s155 specific for linear
(amino acids 173–192) and conformation-dependent
epitopes, respectively, in the large extracellular loop.
We confirmed that both labelled Fabs bound CD81 and
neither Fab affected CD81 mobility or DC by FRAP at
Fig. 1. Effect of HepG2 polarization on lipid dynamics. Quantitative FRAP measurement of DiO-C18 and DiD-C18 dynamics in polarized
(day 7 post plating with a polarization index of 43%) and non-polarized HepG2 cells (day 1 post plating with a polarization index of 2%).
Representative normalized FRAP recovery curves in polarized (Pol, black) and non-polarized (Non Pol, grey) cells are shown. Median
diffusion coefficient (DC) of DiO-C18 (A,B) and DiD-C18 (C,D) in polarized and non-polarized HepG2 cells, where each point represents
one bleached region of interest and the vertical black line represents the median value. Mobile fraction of DiO (polarized – 92.7%,
non-polarized – 86.4%; P < 0.001) and DiD (polarized – 91.5%, non-polarized – 86.4%; P < 0.001). A minimum of 10 cells and 100 ROIs were
measured per parameter. Non-parametric Mann–Whitney t-tests were used to determine the degree of significance (*P < 0.05, **P < 0.001,
***P < 0.0001).
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concentrations up to 1 mg ml-1 (Fig. 3A). Live TIRF micro-
scopic imaging of cell surface bound anti-CD81 Fab frag-
ments enabled us to quantify CD81 dynamics at the basal
membrane with high temporal (100 ms) and spatial (lateral,
50 nm) resolution. Figure 3B represents the distribution of
individual CD81 trajectories at the non-polarized HepG2
cell membrane (50–100 trajectories per cell) calculated
using a linear fit to the mean squared displacement (MSD)
versus time plots. The mode of diffusion was evaluated
within a trajectory using an algorithm based on a neural
network trained to detect Brownian, confined and directed
trajectories. Each identified segment was analysed using
MSD versus time plots (for details, see Experimental pro-
cedures, and for an example, see Fig. S1). Three modes of
diffusion were observed for CD81 trajectories (Fig. 3C):
(i) Brownian diffusion (55  5% of total trajectories) with a
median DC value of 0.17 mm2 s-1, (ii) confined or restricted
diffusion (30  5% of total trajectories) with a low median
DC value of 0.03 mm2 s-1 and a confinement diameter of
367 nm on average and (iii) diffusion with different combi-
nations of Brownian and confined modes referred to as
‘mixed trajectories’ (15  2% of total trajectories). Under
our experimental conditions, CD81 did not show any
directed diffusion. Comparable data were observed with
both anti-CD81 Fabs (Fig. S2). Approximately 30% of con-
fined trajectories overlapped with ensemble anti-CD81 and
anti-CD9 staining of non-polarized HepG2 cells, demon-
strating that sites of single particle confinement overlap
Fig. 2. Effect of HepG2 polarization on CD81 and SR-BI dynamics. HepG2 cells were transfected to express AcGFP–CD81 (A) and
AcGFP–SR-BI (D), and representative confocal images of non-polarized HepG2 cells (day 1 post plating with a polarization index of 2%)
taken at the cell–glass interface are shown. The images were acquired using a 100¥ 1.4NA objective on the Zeiss LSM 780 confocal with
0.44 mm Z sections. Representative normalized FRAP recovery curves for CD81 (B) and SR-BI (E) in polarized (Pol, black) and non-polarized
(Non Pol, grey) cells. Mobile fraction (Mf) of CD81 (polarized – 50.4  19%, non-polarized – 67.7  18%; P < 0.001) and SR-BI (polarized –
61.5  17%, non-polarized – 58.3  16%; P < 0.001). The diffusion coefficient (DC) for CD81 (C) and SR-BI (F) in polarized and
non-polarized HepG2 cells is shown, where each point represents a bleached region of interest and the vertical black line represents the
median value. A minimum of 10 cells and 100 ROIs were measured per parameter. Non-parametric Mann–Whitney t-tests were used to
determine the degree of significance (*P < 0.05, **P < 0.001, ***P < 0.0001).
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with areas of enriched tetraspanin staining or TEMs as
previously reported for CD9 (Espenel et al., 2008). HepG2
polarization reduced the proportion of CD81 trajectories
showing Brownian behaviour, while increasing the fre-
quency of molecules with mixed diffusion (Fig. 3C). Fur-
thermore, we observed a significant reduction in the
diffusion coefficient of Brownian diffusing CD81 molecules
in polarized HepG2 compared to non-polarized cells
(Fig. 3D, Table 1). In summary, these studies show that
polarization slows CD81 diffusion and increases protein
confinement.
HepG2 polarization limits HCVpp dynamics
To investigate whether HepG2 polarization limits HCV
diffusion, we used lentiviral pseudotypes expressing
HCV-encoded E1E2 glycoproteins to study particle traf-
ficking. Lentiviral cores were identified by their incorpora-
tion of GFP-Vpr (Campbell et al., 2007) and HCV E1E2
containing particles by their reactivity with anti-HCV E2
11/20 Fab-Atto647N. Anti-HCV E2 11/20 only bound
HCVpp showing no reactivity with envelope deficient or
VSV-G expressing lentivirus particles (Fig. S3). Of GFP-
Vpr-positive particles, 79% bound anti-HCV E2, showing
that the majority of HCVpp incorporate HCV glycopro-
teins. Given the limited lifetime of the GFP fluorescent
signal we were only able to track particle diffusion with the
Atto-labelled anti-HCV E2 Fab. We confirmed that the
concentration of anti-HCV E2 Fab (5 pM) required to track
particles had no effect on HCVpp infectivity. We noted that
in non-polarized HepG2 cells, the dominant mode of
HCVpp diffusion within the first hour post inoculation was
Brownian (78  3%), with mixed (15  2%) and confined
(5  1%) trajectories comprising a minor component of
the population (Fig. 4A). HepG2 polarization led to an
increase in mixed and confined trajectories and a con-
comitant decrease in the frequency of HCVpp trajectories
with Brownian diffusion (Fig. 4A, Table 1). Furthermore,
HCVpp Brownian DC was significantly reduced on polar-
ized HepG2 cells compared to non-polarized cells, with
speeds of 0.14 mm2 s-1 and 0.07 mm2 s-1, respectively
(Fig. 4B, Table 1), highlighting the similar effect(s) of
HepG2 polarization on HCVpp and CD81 dynamics.
The CD81 C-terminus regulates protein and
HCVpp dynamics
Given the many reports that membrane protein associa-
tion with filamentous actin (F-actin) limits their mobility
(Kusumi et al., 1993; Sako et al., 1998; Treanor et al.,
2011) and cell polarization is accompanied by changes in
the underlying actin cytoskeleton (Delorme-Axford and
Coyne, 2011), we were interested to determine a role for
actin in CD81 dynamics. The tight junction complex
between polarized epithelia is closely associated with the
actin cytoskeleton and subtle changes to the cortical actin
cytoskeleton can lead to a loss of junctional integrity and
barrier formation. Inhibition of actin polymerization with
latrunculin B (LatB) reduced HepG2 tight junction integrity
(data not shown) and we were only able to study the effect
of LatB on CD81 dynamics in non-polarized HepG2 cells.
LatB decreased the frequency of confined trajectories
with an associated increase in the frequency of mixed and
Brownian diffusing trajectories (Fig. 5A). LatB had no
effect on CD81 Brownian DC (Fig. 5B), consistent with a
role for actin polymers to confine CD81 mobility.
The CD81 C-terminal region has been reported to inter-
act with the actin cytoskeleton via ERM (Sala-Valdes
et al., 2006; Chang and Finnemann, 2007; Coffey et al.,
Table 1. Diffusion rates of CD81, SR-BI and HCVpp in different cells assessed by FRAP and SPT.
Methodology Cell Track
Diffusion coefficient (DC), mm2 s-1
Significanceb
Polarized Non-polarized
Median IQR na Median IQR n
FRAP HepG2 CD81 0.07 0.13 250 0.11 0.24 250 ***
SR-BI 0.16 0.24 250 0.14 0.36 250
Huh-7.5 CD81 – – – 0.09 0.15 250
SR-BI – – – 0.13 0.58 250
Huh-6 CD81 – – – 0.12 0.29 250
SR-BI – – – 0.15 0.29 250
PHH CD81 – – – 0.10 0.21 250
SR-BI – – – 0.14 0.48 250
SPT HepG2 CD81 0.11 0.11 3000 0.17 0.16 3000 ***
CD81DC 0.10 0.13 2000 0.10 0.13 2000
HCVpp on HepG2.CD81 0.07 0.21 1500 0.14 0.25 1500 ***
HCVpp on HepG2.CD81DC 0.05 0.14 1500 0.09 0.30 1500
a. n, number of events measured.
b. Comparison of median DC in polarized and non-polarized cells (Mann–Whitney test, ***P  0.001).
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Fig. 3. Single particle tracking of CD81 in polarized and non-polarized HepG2 cells. Initial studies assessed the effect of anti-CD81 2s66 Fab
on AcGFP–CD81 mobility by FRAP methodology. Anti-CD81 2s66 Fab was pre-incubated with cells for 1 h prior to FRAP imaging. The Fab
had no significant effect on CD81 mobility or immobile fraction of DC (A). The image (B) shows CD81 trajectories at the non-polarized HepG2
cell surface and the cartoon depicts representative trajectories with Brownian (B), mixed (M) or confined (C) behaviour. The relative frequency
of anti-CD81 2s66 trajectories in polarized (Pol – white bars) and non-polarized (Non Pol – black bars) cells is shown (C). Scatter plots for
diffusion coefficients calculated from the MSD-t plots for Brownian trajectories in polarized and non-polarized cells, where each point
represents one trajectory with the black line indicating the median, are represented (D). Total and Brownian CD81 DCs are summarized in
Table 1. BMC sampling was utilized to present equivalent trajectories per parameter, where a minimum of 10 cells and 250 trajectories were
measured. Non-parametric Mann–Whitney t-tests were used to determine the degree of significance (*P < 0.05, **P < 0.001, ***P < 0.0001).
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2009). To investigate the role of the CD81 C-terminus in
regulating protein mobility we expressed a mutant protein
lacking the C-terminal region (CD81DC) in HepG2 cells and
confirmed that LatB had no effect on its dynamics (Fig. 5C
and D). We noted a significant reduction in the frequency
of Brownian CD81DC trajectories compared to wild-type
protein (Fig. 5C), prompting us to study mutant protein
localization, dynamics and viral receptor activity. Wild-
type and mutant CD81 showed a comparable staining
pattern in polarized and non-polarized HepG2 cells
(Fig. 6A). We confirmed that CD81DC showed an
increased frequency of confined trajectories and a loss of
Brownian diffusing molecules compared to wild-type
protein in non-polarized cells (Fig. 6B). In addition,
Brownian CD81DC trajectories diffused at a significantly
slower speed than wild-type protein (Fig. 6B and C,
Table 1). In contrast, we failed to observe any significant
differences between wild-type and CD81DC dynamics in
polarized HepG2 (Fig. 6, Table 1). We confirmed that
neither protein affected the ability of HepG2 cells to polar-
ize or to retain 5-chloromethylfluorescein diacetate
(CMFDA) at apical lumens, a marker of tight junction
integrity. These observations support two roles for the
CD81 C-terminus in non-polarized cells: (i) to limit CD81
diffusion in an actin-dependent manner (Fig. 5) and (ii) to
promote Brownian CD81 diffusion (Fig. 6C) via a poten-
tially actin-independent mechanism. The ERM family of
actin binding proteins plays an important role in stabilizing
apical microvilli and has been reported to localize to the
apical domains of polarized airway cells (Berryman et al.,
1993; Berbari et al., 2009). We therefore studied the
localization of phosphorylated ERM in polarized and non-
polarized HepG2 cells. We noted a significant reorgani-
zation of phosphorylated ERM to the MRP2-positive
apical membrane in polarized HepG2 and a reduction in
CD81–ERM colocalization at the basal membrane
(Fig. 7).
To ascertain whether the reduced HCVpp dynamics
observed at the basolateral membrane is CD81-
dependent we compared HCVpp mobility on HepG2 cells
expressing wild-type and CD81DC proteins. We observed
a significant reduction in the proportion of Brownian dif-
fusing HCVpp and an increased number of particles with
mixed or confined diffusion on non-polarized HepG2
expressing CD81DC compared to wild-type protein
(Fig. 8A, Table 1). Furthermore, the Brownian diffusion
coefficient of HCVpp on non-polarized HepG2 cells
expressing CD81DC was significantly reduced compared
to cells expressing wild-type CD81 (Fig. 8B). In contrast,
HCVpp diffusion modes and speed were comparable on
polarized HepG2 expressing wild-type or CD81DC (Fig. 8A
and B). To ascertain whether the altered pseudoparticle
dynamics observed on non-polarized HepG2–CD81DC
impacts virus infection, we compared infection of HepG2
cells expressing wild-type or CD81DC proteins. We con-
firmed that wild-type and mutant proteins were expressed
at comparable levels (Fig. 8C). HCVpp infected non-
polarized cells expressing CD81DC with significantly
reduced efficiency compared to cells expressing wild-type
protein. In contrast, polarized HepG2 expressing wild-
type or mutant CD81 supported comparable rates of
infection (Fig. 8D). In summary, these data support a role
for CD81 dynamics in regulating HCV entry into hepatoma
cells that is dependent on their polarized status.
Fig. 4. Single particle tracking of HCVpp in polarized and non-polarized HepG2 cells. Relative modes of Brownian (B), mixed (M) and
confined (C) HCVpp diffusion at the polarized (Pol – white bars) and non-polarized (Non Pol – black bars) HepG2 cell membrane (A). A
minimum of 10 cells and 250 trajectories were measured per parameter as predetermined by BMC sampling. Scatter plots for HCVpp diffusion
coefficients bound to polarized or non-polarized HepG2 cells were calculated from the MSD-t plots for all Brownian trajectories, where each
point represents one trajectory with the black line indicating the median (B). Total and Brownian HCVpp DCs are summarized in Table 1.
Non-parametric Mann–Whitney t-tests were used to determine the degree of significance (*P < 0.05, **P < 0.001, ***P < 0.0001).
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Discussion
Our live cell imaging studies highlight the dynamic nature
of CD81 and SR-BI as reported for tetraspanin CD9
(Espenel et al., 2008). The principal new observations
from these studies are that hepatoma polarization
restricts CD81, lipid and HCVpp mobility, providing a
mechanism to explain the limited HCV infection of polar-
ized cells (Mee et al., 2009). Our FRAP studies show
similar CD81 diffusion coefficient values to those meas-
ured by SPT and confirm that HepG2 polarization limits
CD81 and DiD/DiO lipid dynamics. In contrast, SR-BI
mobility was not altered by HepG2 polarization, possibly
reflecting the biological function of SR-BI to remove cho-
lesterol esters from lipoproteins into the local plasma
membrane that may overcome global changes in mem-
brane fluidity (Acton et al., 1996; Swarnakar et al., 1999).
Our studies demonstrate a role for the CD81 C-terminal
region to regulate protein dynamics that is dependent on
the polarized status of the cell, possibly reflecting altered
cholesterol and/or lipid constituents of the cell membrane
(Zegers and Hoekstra, 1998). Our observation that
CD81DC has reduced viral receptor activity in non-
polarized HepG2 cells is consistent with an earlier report
by Bertaux and colleagues demonstrating reduced HCVpp
infection of Huh-7 cells (Bertaux and Dragic, 2006). The
observation that CD81DC diffuses slower than wild-type
and supports reduced HCVpp infection of non-polarized
HepG2 cells suggests that CD81 lateral diffusion speed
may limit HCV internalization. In addition, the mutant
CD81 protein may show altered interaction(s) with acces-
sory proteins such as claudin-1 or epidermal growth factor
receptor that play a role in HCV infection (Lupberger et al.,
2011; L. Zona et al., submitted). The reduced diffusion of
Fig. 5. The role of F-actin in CD81 mobility. The relative frequency of anti-CD81 2s66 trajectories in LatB (1 mM) (black bars) or DMSO control
(white bars) treated non-polarized HepG2 cells expressing wild-type (A) or CD81DC (C). Scatter plots for wild-type (B) or CD81DC (D) diffusion
coefficients calculated from the MSD-t plots for Brownian trajectories in treated or untreated cells are shown, where each point represents one
trajectory with the black line indicating the median. Non-parametric Mann–Whitney t-tests were used to determine the degree of significance
(*P < 0.05, **P < 0.001, ***P < 0.0001).
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HCVpp observed on HepG2 cells expressing CD81DC sug-
gests a role for CD81 in regulating pseudoparticle diffusion
at the non-polarized cell membrane. Finally, the ability of
HCVpp to infect HepG2 expressing CD81DC with compa-
rable efficiency independent of their polarized status high-
lights a potential role for this domain in restricting HCV
infection of polarized cells, in contrast to the many reports
suggesting that infection is limited by the access of virus to
tight junction proteins claudin-1 and occludin (Brazzoli
et al., 2008; Burlone and Budkowska, 2009; Delorme-
Axford and Coyne, 2011).
Tetraspanin proteins have received significant attention
as gateways for the assembly and entry of various patho-
gens: including HIV-1, influenza and the malarial parasite
plasmodium, providing potential targets for therapeutic
intervention (Monk and Partridge, 2011). Our observation
that HepG2 polarization reduces CD81 mobility and
increases the frequency of confined trajectories may have
implications for other pathogens that utilize TEMs to enter
or exit their host cell and highlight the importance of
studying membrane protein dynamics in polarized cells.
It is noteworthy that the diffusion speed of HCVpp
closely parallels the CD81 diffusion coefficient on non-
polarized cells (Table 1). Although HCVpp diffusion values
0.07–0.14 mm2 s-1 are comparable to those reported for
the related Dengue virus (van der Schaar et al., 2008),
they are significantly faster than other characterized
viruses, e.g. human papilloma virus type 16 and murine
polyoma virus (Ewers et al., 2005; Schelhaas et al., 2008;
Burckhardt and Greber, 2009; Burckhardt et al., 2011),
which may reflect the different dynamics of specific viral
receptors. Several viruses have been reported to use
actin retrograde flow to infect host cells (reviewed in
Burckhardt et al., 2011). Coller et al. reported the locali-
zation of fluorescent lipid DiD-labelled HCV particles with
CD81, suggesting directed particle diffusion along filopo-
dia in Huh-7 hepatoma cells (Coller et al., 2009). In con-
trast, our SPT studies detected a predominantly Brownian
mode of HCVpp and CD81 diffusion, with no directed
actin-dependent trajectories observed. The differences
between these studies may reflect distinct cell types,
structures being studied or imaging techniques utilized.
However, it is noteworthy that the CD81 diffusion modes
we observed are consistent with reports of other plasma
membrane proteins (Suzuki et al., 2007; Sergé et al.,
2008). The negligible frequency of directed CD81
Fig. 6. CD81 C-terminus regulates protein diffusion and confinement. HepG2 cells were transfected to express wild-type or CD81DC, and
representative confocal images of polarized (day 7 post plating with a polarization index of 44%) and non-polarized (day 1 post plating with
a polarization index of 1%) HepG2 cells taken at the cell–glass interface are shown (A). The images were acquired using a 100¥ 1.4NA
objective on the Zeiss LSM 780 confocal with 0.8 mm Z sections. The relative frequency of wild-type (white bars) and CD81DC (black bars)
Brownian (B), mixed (M) or confined (C) trajectories on polarized (B: 42  5%, 34  4%, M: 24  5%, 19  4%, C: 32  6%, 45  6%) and
non-polarized (B: 55  5%, 29  5%, M: 13  2%, 20  2%, C: 30  5%, 50  5%) HepG2 cells is shown (B). Scatter plots of CD81 and
CD81DC Brownian DC calculated from the MSD-t plots for Brownian trajectories in polarized (0.11, 0.10 mm2 s-1) and non-polarized (0.17,
0.10 mm2 s-1) cells are shown, where each point represents one trajectory with the vertical line indicating the median (C). Total and Brownian
CD81 DCs are summarized in Table 1. A minimum of 10 cells and 250 trajectories were measured per parameter as determined by BMC
sampling. Non-parametric Mann–Whitney tests were used to determine the degree of significance (*P < 0.05, **P < 0.001, ***P < 0.0001).
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Fig. 7. Phosphorylated ERM and CD81 localization in polarized and non-polarized HepG2 cells. Confocal images of HepG2 cells costained
with anti-phosphorylated ERM (pERM) (green) and anti-CD81 (red) (A) or anti-MRP2 (red) (B). Sixteen bit images were acquired with optimal
pixel resolution using a 100¥ Plan Apochromat 1.4NA oil immersion objective on a Zeiss LSM 780 confocal microscope. Representative
maximum projections, constructed from Z sections (0.44 mm thick sections per cell) of polarized and non-polarized HepG2 cells, are shown.
Representative Z sections from the top, middle or bottom of the cell are shown, with the bottom being closest to the glass. Cell nuclei were
counter-stained with DAPI. Scale bars represent 10 mm. Quantitative pERM–CD81 and pERM–MRP2 colocalization analysis at different Z
positions (top, middle and bottom) were calculated in accordance with Zinchuck et al. The colocalization coefficient is weighted for either CD81
or MRP2 expression (C), with the background threshold determined by the fluorescent signal of control isotype-matched IgG-stained HepG2
cells and set as twice the background fluorescent signal plus 3 SD. The change in colocalization between polarized and non-polarized cells
was compared using a Mann–Whitney test (***P < 0.001); no MRP2 expression was detected in non-polarized cells (†).
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trajectories may reflect protein internalization (Farquhar
et al., 2012). Espenel et al. reported a similar lack of
directed CD9 diffusion in PC3 human prostate and HeLa
cancer cells, suggesting that this may be a common prop-
erty of tetraspanin proteins (Espenel et al., 2008).
The functional importance of the CD81 second large
extracellular loop in binding HCV is well recognized
(Zhang et al., 2004; Bertaux and Dragic, 2006); however,
the C-terminal tail has received less attention. The CD81
C-terminus contains 12 amino acids that are conserved
across several animal species, suggesting functional
importance; however, no signalling motifs have been
demonstrated in this short cytoplasmic region (Hemler,
2005). A recent report by Wang and colleagues high-
lighted an essential role for the CD9 C-terminal tail in
tetraspanin function and molecular organization (Wang
et al., 2011). Hence, our results showing a role for the
C-terminus in CD81 mobility may be widely applicable to
other tetraspanin proteins; for example, the C-terminal tail
of CD151 was reported to support integrin-dependent
adhesion strengthening and cell morphology (Lammerd-
ing et al., 2003).
Our data showing that LatB inhibition of actin polymeri-
zation decreased the frequency of confined CD81 trajec-
tories is consistent with the literature describing a
tethering function for F-actin to confine membrane pro-
teins. Furthermore, the negligible effect of LatB on
CD81DC dynamics confirms a role for the C-terminus in
linking CD81 to the actin cytoskeleton (Sala-Valdes et al.,
2006). However, SPT experiments showing reduced
CD81DC DC in non-polarized cells highlight an additional
role for this region in promoting protein diffusion. Our
Fig. 8. CD81 C-terminal tail regulates HCVpp dynamics and HCV infection. The relative frequency of Brownian (B), mixed (M) or confined (C)
HCVpp trajectories on polarized and non-polarized HepG2 cells expressing wild-type (white) and CD81DC (black) protein (A). Scatter plots for
HCVpp diffusion coefficient (DC) in polarized and non-polarized HepG2 cells expressing wild-type or CD81DC are calculated from the MSD-t
plots for Brownian trajectories (B). Each point represents one trajectory with the vertical line indicating the median. A minimum of 10 cells and
250 trajectories were measured per parameter as predetermined by BMC sampling. Non-parametric Mann–Whitney t-tests were used to
determine the degree of significance (*P < 0.05, **P < 0.001, ***P < 0.0001). Total and Brownian CD81 DCs are summarized in Table 1. Cell
surface expression of wild-type and CD81DC in non-polarized HepG2 cells (C). Fifty cells were imaged under the same conditions and the data
expressed as arbitrary fluorescence units (AFU). The rate of HCVpp infection of polarized and non-polarized HepG2 cells expressing wild-type
and CD81DC, where the data are expressed as luciferase relative light units per hour (D). The data are representative of three independent
experiments where infections were performed in triplicate. A one-way ANOVA with a Tukey post test was used to determine the degree of
significance (***P < 0.0001).
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observation that phosphorylated ERM proteins localize
predominantly to the apical lumen of polarized HepG2
cells is consistent with reports in polarized airway cells
(Berryman et al., 1993; Berbari et al., 2009), consistent
with the reduced colocalization of CD81–pERM observed
in polarized cells. A recent study by Orlando and col-
leagues reporting a role for the actin cytoskeleton to both
promote and restrict adhesion molecule L1CAM dynamics
may provide a model for CD81 C-terminal–cytoskeletal
interactions. The authors demonstrated a dual role for the
L1CAM C-terminal tail interacting with ERM or cytoskel-
etal adaptor protein ankyrin, where ERM interaction pro-
moted actin-dependent retrograde L1CAM movement,
whereas ankyrin confined protein movement (Sakurai
et al., 2008; Brachet et al., 2010). Thus, local concentra-
tions of ERM at the basal membrane may provide a switch
to regulate CD81 C-terminal tail interactions with other
components of the cytoskeleton.
In summary, our data suggest that CD81 lateral diffusion
may limit HCV entry. We propose that CD81 needs to freely
diffuse in the cellular membrane to form transient associa-
tions with claudin-1 (Harris et al., 2008; 2010). Our recent
observation that HCV promotes CD81 and claudin-1
co-endocytosis supports a model where virus–CD81 com-
plexes move laterally across the plasma membrane prior to
internalizing (Farquhar et al., 2012). Cao and colleagues
reported that hepatocytes sequester or pre-recruit struc-
tural and enzymatic components of the clathrin-based
endocytic machinery to functional hot spots on the basal
membrane (Cao et al., 2011). These sites of endocytic
uptake may overlap with areas of CD81 confinement and
particle internalization at the basal membrane. Our obser-
vation that polarization reduces the dynamics of both CD81
and HCVpp at the basolateral membrane uncovers a new
pathway for polarized epithelia to restrict pathogen inva-
sion and highlights the importance of studying virus–host
cell interactions in polarized cell systems.
Experimental procedures
Cell lines and reagents
HepG2 cells were propagated in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 10% fetal bovine serum and
1% non-essential amino acids. HepG2 cells naturally lack CD81
expression and were transduced to express exogenous human
CD81, CD81 lacking a C-terminal region (CD81DC) or AcGFP-
tagged CD81 or SR-BI as previously described (Harris et al.,
2008). Latrunculin B (LatB) was purchased from Sigma and
fluorescent membrane dyes DiO-C18 and DiD-C18 from Invitro-
gen. Fab fragments of anti-CD81 monoclonal antibodies 2s66,
2s155 (Harris et al., 2008), anti-HCV E2 11/20 (Hsu et al., 2003)
were prepared using papain cleavage and labelled with single
photostable fluorophores, Atto647N or Cy3B, purchased from
Atto-Tech or GE HealthCare, as previously described (Espenel
et al., 2008).
Quantification of HepG2 polarity
HepG2 cells were grown on 13 mm diameter borosilicate glass
coverslips (Fisher Scientific, UK) to the time point required and
fixed in 3% paraformaldehyde at room temperature for 30 min.
Cells were stained for apical multidrug-resistant protein 2 (MRP2)
(anti-MRPR clone M2 III-6; Abcam Cambridge, UK) in 0.1%
Triton (Sigma-Aldrich, UK), 0.5% bovine serum albumin (BSA)
in phosphate-buffered saline (PBS) and Alexa-Fluor 488-
conjugated goat anti-mouse. Cell nuclei were visualized using
4′, 6′-diamidino-2-phenylindole (DAPI; Invitrogen). The polarity
index was determined by counting the number of MRP2-positive
apical structures per 100 nuclei using a Nikon Eclipse TE2000-S
fluorescence microscope as previously reported (Mee et al.,
2009). Polarity indices of 40–45 are routinely observed 7 days
post plating. Since at least two cells are required to form a bile
canaliculus, this corresponds to at least 80–90% of cells devel-
oping polarity.
Hepatitis C virus pseudoparticle genesis and infection
Pseudoviruses expressing luciferase or GFP-Vpr were generated
as previously reported (Hsu et al., 2003; Campbell et al., 2007).
Briefly, 293T cells were transfected with an equal ratio of plas-
mids encoding HIV provirus expressing luciferase, GFP-Vpr and
HCV strain H77 E1E2 envelope glycoproteins, VSV G or empty
vector. Supernatants were harvested 48 h post transfection,
pooled and filtered. Virus containing media was added to target
cells plated at 1.5 ¥ 104 cells cm-2 for 8 h, unbound virus was
removed by washing every 30 min and the cells incubated at
37°C. Seventy-two hours post infection the cells were lysed,
substrate added and luciferase activity measured for 10 s in a
luminometer (Lumat LB 9507). Specific infectivity was calculated
by subtracting the mean Env-pp relative light unit (RLU) signal
from the HCVpp signal.
Fluorescence recovery after photobleaching (FRAP)
Cells transduced to expressAcGFP.CD81 andAcGFP.SR-BI were
plated onto Mattek glass bottomed dishes at a density of 1.5 ¥ 104
cells cm-2 and imaged using a 100¥ Plan Apochromat 1.4NA oil
immersion objective on a Zeiss LSM 780 confocal microscope with
a GaAsP spectral detector. Sixteen bit images were attained with
optimal pixel resolution. Tagged proteins were excited with the
argon 488 laser (DiD-labelled membranes were excited with the
633 laser) and initial images acquired with low laser power
(0.1–1% transmission), photobleaching was performed with full
laser power for 20 iterations on selected circular regions of interest
(ROIs) identified in the planar membrane. Subsequent recovery
images were collected using low laser power at 0.18 s intervals for
approximately 2 min, until ROI recovery had reached a plateau.
Only a single Z section was bleached and imaged, typically the
basal side of the cell contacting the coverslip. The mean fluores-
cent intensity over time was obtained for the photobleached ROI,
a background ROI (containing no cells) and an unbleached ROI in
the cell of interest. ROIs were selected using the Zeiss Zen
analysis software. Changes in fluorescence following photob-
leaching were normalized for fluctuations in image capture, laser
power and overall fluorescence loss in the cells by subtracting the
background and unbleached ROI using the Zeiss Zen software.
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The values obtained for the photobleached ROI were converted to
relative fractional recovery, where the prebleach fluorescence
intensity values equal to 100%. Data were imported into GraphPad
Prism and fitted using a single exponential decay algorithm,
Y = span (1-exp (-K*X)) + plateau. The span and plateau were
used to calculate mobile fraction. The diffusion coefficient (D) was
calculated using a simple two-dimensional diffusion model for a
circular bleach ROI: D = 0.224 ¥ (radius2/t1/2) (Axelrod et al.,
1976). Bootstrap Monte Carlo sampling demonstrated that a
minimum of 10 cells and 100 ROIs were required to represent the
population.
Single particle tracking of anti-CD81 Fabs and
pseudoparticle by total internal reflection fluorescence
(TIRF) microscopy
A multicolour single-molecule imaging TIRF system, equipped
with a Plan Fluor 100X/1,45 NA objective (Zeiss, Le Peck,
France), was used for SPT studies. The total internal reflection
angle was manually adjusted for each experiment. All experi-
ments were performed with a 100 ms integration time. To achieve
maximal specificity in the detection of two fluorescent signals,
alternating-laser excitation was performed using an acousto-
optical tuneable filter and controller (AOTF; AA Optoelectronics,
Les Chevreuses, France) (Margeat et al., 2006). All movies were
analysed using designated software, named ‘PaTrack’ imple-
mented in visual C++. In our software, the detection, estimation of
positions and reconnection of detected molecules are carried out
sequentially. Briefly, the centre of each fluorescence peak was
determined with sub-pixel resolution by fitting a two-dimensional
elliptical Gaussian function with a background value. Trajectories
are constructed in the sequence, frame after frame. The associa-
tion of spots of sequential images within trajectories is based on
a nearest-neighbour rule. Overlapping tracks are discarded or
construction in the sequence of two fluorescent molecules is
stopped when they overlap (to be kept and analysed, the length of
the trajectories should be over 40 frames). However, the density
of the particles per frame was sufficiently low to minimize over-
lapping. Apparent diffusion coefficient values were determined
from a linear fit between the first and fourth points (D1–4) of the
MSD versus time lag according to Kusumi et al. (1993). The mode
of diffusion was determined using a new algorithm based on a
back-propagation neural network that has been trained using
synthetic trajectories to detect pure Brownian, confined and
directed motion modes (H.J. Harris et al., manuscript in prepara-
tion). Thanks to a sliding window, the trajectory is analysed and
the different modes can be confidently detected within a trajectory
for segments larger than 10 frames. The algorithm has been
tested with simulated trajectories displaying pure Brownian, con-
fined or directed behaviour or a combination of these three modes
and successfully applied to a set of single-molecule experiments
previously recorded for tetraspanins (Espenel et al., 2008). For
each identified segment, the MSD curve was linearly fitted
(Brownian) or adjusted with a quadratic curve (4Dt + n2t2)
(directed diffusion) or exponential curve L2/3(1-exp(-12Dt/L2)
(confined diffusion), where L is the side of a square domain, the
confinement diameter being related to L by dconf = (2/√p)L).
Single particle tracking CD81 diffusion
Cells were incubated with phenol red free supplemented DMEM
at 37°C for 10 min with anti-CD81 Fab-Atto647N fragments
(3 pM). Following incubation the cells were washed three times in
phenol red free DMEM and single fluorophores visualized with
the TIRF evanescent wave (~ 100 nm depth) on the basal side of
the cell contacting the coverslip. One thousand frame movies
were attained with 100 ms integration time. Single fluorophores
were identified by monitoring single-step fluorescence bleaching.
Single particle tracking pseudoparticle diffusion
GFP.Vpr-labelled HCVpp were incubated with phenol red free
supplemented DMEM at 37°C for 10 min with anti-HCV E2 11/20-
Atto647N Fab fragments (5 pM) prior to cell inoculation. Cells
were incubated with labelled virions for 10 min and unbound virus
removed by washing prior to monitoring particle diffusion at the
basal cell surface with the TIRF evanescent wave. One thousand
frame movies were attained with 100 ms integration time. Virions
expressing HCV glycoproteins were identified as those express-
ing GFP.Vpr and labelled with anti-HCV E2 11/20-Atto647N Fab
(Fig. S3).
Ensemble costaining
Cells were incubated in phenol red free DMEM at 37°C for 10 min
with Cy3B-labelled anti-CD9/CD81 Fab fragments (3 nM) for
ensemble labelling and Atto647N-labelled anti-CD81 Fab frag-
ments (3 pM) for SPT experiments. A maximum projection of
Cy3B from the 1000 frame movie provided the overall staining for
CD9 or CD81 indicating domains of enriched expression. The
ensemble labelling was overlayed with the SPT data and the
frequency of colocalizing trajectories calculated.
Protein colocalization
Quantitative colocalization was measured according to published
work (Zinchuk et al., 2007). Sequential scanning confocal Z sec-
tions (~ 0.44 mm thick) of cells were obtained with optimal pixel
resolution using a 100¥ Plan Apochromat 1.4NA oil immersion
objective on a Zeiss LSM 780 confocal microscope. Microscope
settings were optimized for each fluorescent protein to obtain the
highest signal to noise ratio, while controlling for cross-talk. The
background fluorescent signal was determined by measuring
the signal of control isotype-matched IgG binding to cells. The
background threshold was set at twice the background fluores-
cent signal plus 3 standard deviations. The cells being analysed
were extracted from the whole image and single Z sections
analysed using the colocalization tool in the Zeiss Zen software.
Since the proteins are not expressed equally throughout the cell,
the Mander’s overlap coefficient and colocalization coefficient m1
and m2, respectively (Zinchuk et al., 2005), were utilized instead
of the Pearson’s correlation coefficient. The results are displayed
as the weighted colocalization of CD81 or MRP2.
Cell surface expression of proteins
Confocal Z sections (0.44 mm) of cells labelled with saturating
levels of anti-CD81 Fab-Atto647N (40 mM) and membrane dye
DiO (1 mg ml-1) were acquired with optimal pixel resolution using
a 100¥ Plan Apochromat 1.4NA oil immersion objective on a
Zeiss LSM 780 confocal microscope. The plasma membrane
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expression of CD81 was quantified using the overlay and inten-
sity tools within the Zeiss Zen software. DiO staining was used to
identify the plasma membrane and the fluorescence of bound
anti-CD81 Fab defined protein expression level as arbitrary fluo-
rescence units (AFU).
Statistics – bootstrap Monte Carlo (BMC) sampling
The mobile fraction and diffusion coefficient of CD81 calculated
from FRAP and SPT studies in non-polarized HepG2 cells were
randomized and 10 samples with increasing number of values (n)
collected. The coefficient of variation was calculated for the 10
samples with increasing n, demonstrating that 10 samples with a
minimum of 250 trajectories for single-molecule studies and 100
ROI from 10 cells for FRAP studies were sufficient to represent
the population. The correct choice of equation was calculated by
running Akaikes information criterion and extra sum of squares
F-test, assuming simpler model/equation unless a P-value less
than 0.05. Given the non-Gaussian distribution of CD81 and
HCVpp SPT dynamics we compared the median and interquartile
range values between cells. The infection data are represented
as the mean  SEM unless otherwise stated, as the values fit a
Gaussian distribution. Corrections for multiple sampling (Bonfer-
roni method and Dunnett’s multiple comparison test) were used
where appropriate. Statistical analyses were carried out in the
Prism 5 package (GraphPad software, San Diego, CA), and
probabilities are represented as P < 0.05 (*), P < 0.01 (**) and
P < 0.001 (***).
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Supporting information
Additional Supporting Information may be found in the online
version of this article:
Fig. S1. MSD plot and movie, movie of CD81 dynamics and
MSD analysis. Example of CD81 single-molecule tracking using
Atto647N-labelled Fab fragments (A). A neural network (see
Experimental procedures) is used to determine CD81 behaviour
within a trajectory. Each identified segment is then analysed
using MSD analysis and a plot of Brownian (B) and confined (C)
segments. The first four points are used to determine the appar-
ent diffusion coefficient of the molecule. The fit of the confined
trajectory has been performed using 50% of the dots.
Fig. S2. CD81 single-molecule tracking profiles. The relative fre-
quency of CD81 trajectories with Brownian (B), mixed (M) or
confined (C) behaviour observed with anti-CD81 Fabs 2s66 and
2s155 (A). A minimum of 10 cells and 250 trajectories were
measured per parameter as predetermined by BMC sampling.
Scatter plots for Brownian CD81 diffusion coefficients measured
with anti-CD81 Fabs 2s66 or 2s155 in non-polarized HepG2
cells, where the median Brownian DC values for 2s66 and 2s155
are 0.17  0.2 mm2 s-1 and 0.16  0.2 mm2 s-1 respectively (B).
Each point represents one trajectory with the vertical line indicat-
ing the median.
Fig. S3. Anti-HCV E2 specificity. Representative TIRF images of
GFP.VPR HCVpp, Env-pp or VSV Gpp bound to non-polarized
HepG2 cells costained with anti-HCV E2 11/20 Fab-Atto647N.
Seventy-nine per cent of GFP.VPR expressing HCVpp costained
with anti-HCV E2 11/20. The threshold for the green and red
signals was defined as twice the mean background plus 3 stand-
ard deviations of uninfected HepG2 cells. Colocalization was
established following the analysis of 40 cells. Scale bar repre-
sents 10 mm.
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